MedAdvisor Limited announced the following changes to its Board and senior executive team as the company enters its next growth phase. Anthony Tassone to be appointed Non-executive Director following the acquisition of GuildLink and investment by Guild Group into MedAdvisor. Following MedAdvisor's agreement to acquire GuildLink Pty Limited (GuildLink) and Guild Group Holdings Limited's (Guild Group's) investment and resulting substantial holding in MedAdvisor, Anthony Tassone is to be appointed to the Board of MedAdvisor as a nominee for the Guild Group, effective 27 July 2022 (subject to completion of the acquisition). A community pharmacist and proprietor of community pharmacies for 16 years, Anthony has been the Victorian Branch President of the Pharmacy Guild of Australia (PGA) since 2013. In addition he is the National Vice President of Health Economics and Policy for PGA, which leads engagement and negotiation with the Commonwealth Government and Department of Health for five-yearly community pharmacy agreements. His 20-year career in the pharmacy sector encompasses serving on a range of advisory boards for multi-national pharmaceutical companies, and other advisory roles with State and Federal governments. Executive Director Josh Swinnerton to retire from the Board and remain as an executive: Co-founder and Executive Director Josh Swinnerton has decided to step away from MedAdvisor's board effective 27 July 2022. Josh will remain involved in the organisation in his executive capacity, continuing to provide support and innovation advice across the business. Co-founding MedAdvisor in 2012, Josh was a key member of the team that identified the challenges and opportunities around medication management and adherence. Recently Josh
spent several years in the US exploring opportunities that ultimately led to the acquisition and successful integration of Adheris.